
Active surveillance:
May be recommended for selected low-risk localised cancers. Monitoring can include PSA tests, examinations, MRI and repeat biopsy. Treatment begins if the cancer shows signs of progression.

From diagnosis and treatment planning to recovery and long-term follow-up, experience care that considers your strength, urinary health, sexual wellbeing, nutrition and overall quality of life.

A diagnosis can bring many questions at once. Let us begin with the basics.
Prostate cancer develops when abnormal cells grow in the prostate gland, located below the bladder. Most prostate cancers are adenocarcinomas arising from glandular cells. Some prostate cancers grow slowly and may never cause significant harm, while others are more aggressive and can spread to lymph nodes, bones or other organs. Many patients have no symptoms when the cancer is first detected, and it may be identified after a prostate-specific antigen, or PSA, blood test. A raised PSA does not automatically mean cancer. Further assessment may include examination, prostate MRI and biopsy. The biopsy determines the Gleason score and Grade Group, which help guide treatment planning.
Your urologist or oncologist may have discussed surveillance, surgery, radiation, hormone therapy or systemic medicines.

Cancer Healer Therapy (CAM) is supportive integrative care used alongside treatment prescribed by your urologist or oncologist, not instead of it.
The supportive plan may consider appetite, fatigue, sleep, emotional wellbeing, treatment-related discomfort and recovery after surgery or radiation.
Herbal medicines and supplements can interact with hormone therapy, chemotherapy, targeted medicines, immunotherapy, blood thinners and other treatments. Some may also affect liver or kidney function, bleeding risk or hormone pathways.
Support may begin before surgery, radiation, hormone therapy or systemic treatment, with attention to urinary symptoms, nutrition, muscle strength, bone health and current medicines.
Most prostate cancers are adenocarcinomas arising from glandular cells of the prostate.
Other rare prostate cancers can also occur. Identifying the exact tumour type is important because different forms may behave differently and require different treatment approaches. The tumour type is considered alongside the PSA level, Grade Group, stage, imaging findings and other clinical factors when planning appropriate care.


Here’s exactly what happens from your first conversation with us to ongoing support during treatment.
We discuss your diagnosis, PSA results, biopsy, scans, symptoms and current or planned treatment.
The team reviews PSA, Grade Group, stage, risk group, imaging, urinary and sexual symptoms, bone health and current medicines.
Supportive care is developed around the treatment or surveillance plan recommended by your oncology team.
Herbal medicines, supplements and special diets should be disclosed to the treating doctor.
The plan may be reviewed as PSA, symptoms, scans and treatment needs change.
One point of contact supports appointments and follow-up communication.

Meet Dr. Tarang Krishna, MD - Cancer Healer Center
Dr. Tarang Krishna has spent over two decades developing and refining Cancer Healer Therapy, working with a multidisciplinary team across 30+ centres in India.
His work has been recognised for innovative cancer care and brings a coordinated, supportive approach to every patient journey.

Every cancer journey is personal. Read experiences shared by patients and families about the consultations, communication, follow-up and support they received at Cancer Healer Center.
4.9 Stars | 5479 Reviews
No. PSA can also rise because of benign enlargement, prostatitis, infection or recent prostate procedures. PSA alone cannot confirm cancer.